Not very attention-grabbing, but significantly undervalued due to a large drop in earnings below expectations.
Buy on the dip at the target stock price of $20.
Due to the low level of attention, the volume is not very high, and although it is an upward trend, the price increase range is small, so a medium-term perspective may be necessary.$Silence Therapeutics (SLN.US)$
Unsupported feature.
Please use the mobile app.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more